- Article metrics
- Last updated: Wed, 15 Oct 2025 13:40:55 Z
A phase I study of the CDK4/6 inhibitor ribociclib combined with gemcitabine in patients with advanced solid tumors
Access & Citations
-
- 1932
- Article Accesses
-
- 0
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.